Pfizer Oncology announces FDA approval of ELREXFIO™ (elranatamab-bcmm).
On August 24th, 2023
The following information is available for State Society review:
§ Full Prescribing Information Including Boxed Warning and Medication Guide
The following information is available for State Society review:
§ Full Prescribing Information Including Boxed Warning and Medication Guide
No comments have been posted yet.